Skip to main content

Table 3 Univariate analysis of survival

From: Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study

  Beta Wald
statistic
P-value*
ASA-classification -0.034372 0.034097 0.853501
Nutrition status -0.059647 0.310746 0.577226
Smoking -0.282645 2.403644 0.121063
Alcohol consumption -0.294566 2.635858 0.104485
Hepatopathy 0.066506 0.091186 0.762676
Pulmonary disease -0.062020 0.114867 0.734672
Cardial disease -0.276026 2.215080 0.136678
Diabetes -0.241763 1.005458 0.316001
Secondary carcinoma 0.196181 0.924205 0.336381
Vital Capacity (VC) -0.239513 2.552092 0.110158
FEV 1 -0.296171 3.468683 0.062550
Age 0.008591 0.774818 0.378737
Gender 0.319681 1.808111 0.178745
Procedure 0.081361 0.364907 0.545798
Histology 0.362451 4.884958 0.027099
Localization 0.241270 5.437840 0.019711
Contraindication
for surgery
-0.041959 1.555456 0.212341
Causes of incurability -0.053454 0.340351 0.559631
Site of metastases 0.087241 1.488161 0.222511
Type of metastases -0.346926 2.826217 0.092746
Therapy -0.199524 7.805245 0.005213
BMI -0.003725 0.050582 0.822056
  1. *P-values in bold depict statistical significance
  2. BMI: body mass index; ASA: American Society of Anesthesiologists classification; FEV 1 : Forced expiratory volume in 1 s